Molecular Mimicry, Ankylosing Spondylitis and Reactive Arthritis -Something Missing?

References

• The Pathogenetic role of HLA-B27. TEW Feltkamp. Scand J Rheumatol 1990; Suppl. 87: 9–61
   Google Scholar
• Yu D TY, Ogasawara M, Hill J L, Kono D H. Study of Reiter's syndrome, with special emphasis on Yersinia en-terocolitica. Irnrnunol Rev 1985; 86: 2745
   Web of Science ®Google Scholar
• Van Bohemen C G, Grumet F C, Zanen H C. Identification of HLA-27M1 and -M2 cross reactive antigens in Klebsiella, Shigella and Yersinia. Immunology 1984; 52: 607–10
   PubMed Web of Science ®Google Scholar
• Raybourne R B, Bunning V K, Williams K M. Reaction of anti-HLA-B monoclonal antibodies with envelope proteins of Shigella species. Evidence for molecular mimicry in the spondyloarthropathies. J Immunol. 1988; 140: 3489–95
   PubMed Web of Science ®Google Scholar
• Zhang J, Hamachi M, Hawachi T, Zhao Y, Yu D TY. The bacterial outer membrane protein that reacts with anti-HLA-B27 antibodies is the OMPA protein. J Immunol 1989; 143: 2955–60
   PubMed Web of Science ®Google Scholar
• Williams K M, Raybourne R B. Demonstration of cross-reactivity between bacterial antigens and HLA Class I molecules using monoclonal antibodies produced against Shigella Flexneri. Infect lmmun 1990; 58: 1774–81
   PubMed Web of Science ®Google Scholar
• Raybourne R B, Williams K M. Monoclonal antibodies against an HLA-B27–derived peptide react with an epitope present on bacterial proteins. J Immunol 1990; 145: 2539–44
   PubMed Web of Science ®Google Scholar
• Ebringer A, Maines M, Praszynska T. Spondyloarthritis, uveitis, HLA-B27 and Klebsiella. Immunol Rev 1985; 86: 101–16
   PubMed Web of Science ®Google Scholar
• Schwimmbeck P L, Yu D TY, Oldstone M BA. Autoanti-bodies to HLA-B27 in the sera of HLA-B27 patients with ankylosing spondylitis and Reiter's syndrome. J EXp med. 1987; 166: 173–81
   PubMed Web of Science ®Google Scholar
• Raybourne R B, Williams K M, Cheng X K, Yu D TY. Demonstration of shared epitopes between bacterial proteins and HLA Class-I proteins using monoclonal antibodies. Scand J Rheumatol 1990; Suppl 87: 134–9
   Google Scholar
• Seager K, Bashi H V, Geczy A F, Edmonds J, De Vere-Tyndall A. Evidence for a specific B27–associated cell surface marker on lymphocytes of patients with ankylosing spondylitis. Nature 1979; 277: 68–70
   PubMed Web of Science ®Google Scholar
• Druery C, Bashir H V, Gaczy A F, Alexander K, Edmonds J P. Search for Klebsiella cell wall components cross-reactive with lymphocytes of B27(+) AS(+)-individuals. Human Immunol 1980; 1: 151–60
   PubMed Web of Science ®Google Scholar
• Geczy A F, Alexander K, Bashir H V, Edmonds J P, Upfold L, Sulivan J. HLA-B27, Klebsiella, and ankylosing spondylitis: biological and chemical studies. Immunol Rev 1983; 70: 23–50
   PubMed Web of Science ®Google Scholar
• Archer J R, Stubbs M M, Currey H LF, Geczy A F. Anti-serum to Klebsiella K43 BTS 1 specially lyses lymphocytes of HLA-B-27–positive patients with ankylosing spondylitis from a London population. Lancet 1985; 1: 344–5
   PubMed Web of Science ®Google Scholar
• Geczy A F, Van Leeuven A, Van Rood J J, Ivanyi P, Cats A. Blind confirmation in Leiden of Geczy factor on the cells of Dutch patients with ankylosing spondylitis. Human Immunol 1986; 17: 23945
   Web of Science ®Google Scholar
• Beukelman C J, van Quarles Ufford H C, VanBree R PMJ, Aerts P C, Nieuwenhoff C, Reerink G, Van Leeuwen A, Van Dijk H. Trial and error in producing ankylosing-spondylitis-selective antisera according to Andrew Geczy. Scand J Rheumatol. 1990; Suppl 87: 74–80
   Google Scholar
• Breur-Vriesendorp B S, Post F A, de Waal L P, Blokland E, Pool J, Van der Linden S, Dekkersaeys B J, Goulmy E, Ivanyi P. Blood lymphocytes from ankylosing spondylitis patients fail to induce-specific cytotoxic T lymphocytes. Human Immunol 1989; 25: 149–55
   PubMed Web of Science ®Google Scholar
• Ewing C, Ebringer R, Tribbick G, Geysen H M. Antibody activity in ankylosing spondylitis sera to two sites of HLA-B27.1 at the MCH groove region (within sequence 65–85) and to a Klebsiella pneumoniae nitrogenase reductase peptide (within sequence 181–199). J Exp Med 1970; 171: 163540
   Google Scholar
• Tsuchiya N, Husby G, Williams R C, Jr. Studies of humoral and cell-mediated immunity to peptides shared by HLA-27.1 and klebsiella pneumoniae nitrogenase in ankylosing spondylitis. Clin Exp Immunol 1989; 76: 354–60
   PubMed Web of Science ®Google Scholar
• Ivanyi P. Dysfunction of HLA-B27. Scand J Rheumatol 1960; Suppl 87: 51–69
   Google Scholar
• Husby G, Tsuchiya N, Schwimmbeck P L, Kent A, Pahle J A, Oldstone M BA, Williams R C, Jr. Cross-reactive epitope with klebsiella pneumoniae nitrogenous in articular tissue of HLA-B27(+) patients with ankylosing spondylitis. Arthritis Rheum 1989; 32: 437–45
   PubMed Web of Science ®Google Scholar
• Stieglitz H, Fosmire S, Lipsky P E. Identification of a 3–Md plasmid from Shigella flexneri associated with reactive arthritis. Arthritis Rheum 1989; 32: 937–46
   PubMedGoogle Scholar
• Tsuchia N, Husby G, Williams R C, Jr, Stieglitz H, Lipsky P, Inman R D. Auto antibodies to the HLA-B27 sequence cross-react with the hypothetical peptide from the arthritis-associated shigella plasmid. J Clin Invest 1960; 86: 1193–203
   Google Scholar
• Hammer R E, Maika S D, Richardson J A, Tang J P, Taurog J D. Spontaneous inflammatory disease in trans-genic rats expressing HLA-B27 and human &m: an animal; model of HLA-B27–associated human disorders. Cell 1990; 63: 1099–112
   PubMed Web of Science ®Google Scholar
• Archer J R, Badakere S S, McLean I L. Post-translational heterogeneity of HLA-B27: a new hypothesis for its role in inflammation. Br J Rheumatol 1989; 28: 143, (Abstract)
   PubMedGoogle Scholar